Companion Diagnostics
News on companion diagnostics and drug/test co-development.
OSE Immunotherapeutics Starts Registration-Directed Tedopi Trial in Second-Line NSCLC
The firm is also evaluating a test to identify HLA-A2-positive patients eligible for the neoepitope-based cancer vaccine.
Qiagen, Eli Lilly Collaborate on Alzheimer's Risk Dx Panel
The firms will develop a multiplex PCR panel for the QiaStat-Dx system that detects APOE genotypes.
Foundation Medicine, Syndax Pharmaceuticals Partner to Develop CDx for AML Treatment
The companion diagnostic assay, for a drug under development by Syndax, will identify acute myeloid leukemia patients with an NPM1 mutation.
Foundation Medicine Nets FDA Approval for Tissue, Liquid NGS CDx for Lynparza Combo
The FDA approved FoundationOne CDx and FoundationOne Liquid for identifying BRCA1/2-mutated mCRPC patients eligible for Lynparza, Zytiga, and a steroid.
Guardant Health Liquid Biopsy CDx Gets Japanese Regulatory Approval for Janssen Lung Cancer Drug
Patients with inoperable or recurrent NSCLC and EGFR exon 20 insertion mutations may be eligible for Janssen Pharmaceutical's amivantamab-vmjw.
Jul 24, 2024